RE:Device updateWhat did this N/R tell us ? Nothing !
The Dermal Injector is no further ahead than it was at the last AGM. Now that AMI announced last year it was terminating it's relationship with Replicel we now hear in this N/R today they are looking for a North American contract manufaturer. That is exactly what we were told at the last AGM. So actually we are no further ahead.
What did we her about the Arbitration: Nothing. We will hear something by law when a material event occurs......when that occurs.
O.K. moving on.